MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis

Published:2013-12-02 Issue:3 Volume:74 Page:499-505
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Choi Ivy Y,Gerlag Danielle M,Herenius Marieke J,Thurlings Rogier M,Wijbrandts Carla A,Foell Dirk,Vogl Thomas,Roth Johannes,Tak Paul P,Holzinger Dirk

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference42 articles.

1. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis;Tak;Arthritis Rheum,2000

2. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial;Emery;Ann Rheum Dis,2008

3. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition;Genovese;N Engl J Med,2005

4. Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFalpha blocker failure;Kekow;Biologics,2012

5. Anti-TNF therapy;Thalayasingam;Best Pract Res Clin Rheumatol,2011

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis;Arthritis Research & Therapy;2024-06-25

2. Frequency of irritable bowel syndrome in spondyloarthritis: a multicentric cross-sectional study and meta-analysis;RMD Open;2024-01

3. Anti-Tumour Necrosis Factor and New Paradigms for Therapies Using Antibodies;Molecular Biology of B Cells;2024

4. Discriminating signal from noise: the biological variation of circulating calprotectin in serum and plasma;Clinical Chemistry and Laboratory Medicine (CCLM);2023-12-12

5. A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?;ESC Heart Failure;2023-12-11